𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer

✍ Scribed by Seung Tai Kim; Joon Oh Park; Jeeyun Lee; Kyu Taek Lee; Jong Kyun Lee; Seong-Ho Choi; Jin-Seok Heo; Young Suk Park; Won Ki Kang; Keunchil Park

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
134 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expanded phase II trial of gemcitabine a
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
✍ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger

A phase 1 study of fixed dose rate gemci
A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer
✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit